Prelude Capital Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Buy |
+31,066
| New | +$632K | 0.06% | 373 |
|
|
2024
Q2 | – | Sell |
-16,300
| Closed | -$684K | – | 1156 |
|
|
2024
Q1 | $684K | Sell |
16,300
-10,212
| -39% | -$429K | 0.04% | 445 |
|
|
2023
Q4 | $1.05M | Buy |
+26,512
| New | +$1.05M | 0.07% | 244 |
|
|
2017
Q4 | – | Sell |
-1,220
| Closed | -$52K | – | 1253 |
|
|
2017
Q3 | $52K | Buy |
+1,220
| New | +$52K | ﹤0.01% | 991 |
|
|
2015
Q3 | – | Sell |
-926
| Closed | -$350K | – | 1421 |
|
|
2015
Q2 | $350K | Hold |
926
| – | – | 0.05% | 368 |
|
|
2015
Q1 | $387K | Buy |
+926
| New | +$387K | 0.05% | 403 |
|